The FDA has the authority to enforce mandatory recalls for medical devices and recommend recalls for prescription and over-the-counter drugs, but cannot enforce drug recalls.
The $3.2 billion budget is $40.8 million more than the FDA’s 2020 budget.
It is unclear whether the Senate will finalize the budget before the beginning of the next fiscal year on Oct. 20, Endpoints News reported. The Senate must approve it before the FDA gets the authority to enforce drug recalls.
Find the House’s summary of the budget here.
More articles on pharmacy:
Walgreens CEO steps down
AstraZeneca, Daiichi Sankyo partner in $6B cancer drug deal
Trump signs 4 executive orders targeting drug prices: 6 things to know
